EXISTING PARTNERS

Onxeo designs and develops innovative drugs with unique mechanisms of action in rare and orphan cancers, with a focus on DNA-targeting and resistance to existing treatments.

BECOME PARTNER

iQone Healthcare, as part of the Clinigen group, offers market access services accross Europe. We collaborate with reliable and reputed partners to distribute specialty compounds in oncology, hematology and rare diseases.

CONTACT POINT FOR PARTNERS

WHY WE ARE SO DIFFERENT

iQone Healthcare Group is dedicated to oncology, haematology and rare diseases and offers Early Access Programs (EAP) in partnership with Onxeo.

We strive for effectiveness by taking fast decisions which are transparent and consistent. We are responsive to demands and flexible in solving them.

In addition, our medical and scientific expertise enables us to select and offer products of the highest repute.

INTERNATIONAL PRESENCE

iQone Healthcare Group is headquartered in Versoix, Switzerland, but is active in many European markets in partnership with companies such as Onxeo. Our regional offices are located in Munich/Germany, in Lyon/France, in Milan/Italy and in Madrid/Spain.